StockData
ACLSNasdaqSpecial Industry Machinery, NECFiscal year ends December 31

AXCELIS TECHNOLOGIES INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$111.21+2.86 (+2.64%)

Close on Oct 19, 2026

Market cap
$3.46B
P/E (TTM)
37.3
Dividend yield
–

About Axcelis Technologies

Special Industry Machinery, NEC, SIC 3559

Axcelis Technologies designs, manufactures, and services ion implantation equipment and other processing machinery utilized in semiconductor chip fabrication. Its primary product lines include high-energy, high-current, and medium-current ion implanters, featuring the Purion platform and Ovation batch systems, alongside specialized tools for power device applications. The company also provides aftermarket lifecycle solutions, including spare parts, equipment maintenance, upgrades, pre-owned machinery, and technical training. Axcelis supplies its equipment and services to semiconductor manufacturers worldwide, including integrated device manufacturers, pure-play foundries, and chip designers.

The company is headquartered in Beverly, Massachusetts, where it operates a manufacturing facility, an advanced technology center, and a logistics center. It also maintains an operations facility in South Korea. Axcelis conducts sales and marketing activities across the United States, Europe, and Asia, with employees and products located in 27 countries globally.

Summary of the business section of Axcelis Technologies's latest annual report, written by StockData.

Company profile

Company

Legal name
AXCELIS TECHNOLOGIES INC
Founded
1978
Headquarters
Beverly, MA
Address
108 Cherry Hill Drive 01915
Phone
(978) 787-4000
Employees
1,465, Dec 31, 2025
Industry
Special Industry Machinery, NEC
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, Boston, Massachusetts

Stock & identifiers

Ticker
ACLS
Exchange
Nasdaq
IPO date
Jul 11, 2000
Shares outstanding
31M, Aug 3, 2026
Public float
$2.18B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
1-for-4 reverse, Aug 8, 2016; 1-for-4 reverse, Jul 1, 2016
SEC CIK
1113232
CUSIP
054540208
ISIN
US0545402085
LEI
529900HF9B6NL1QG9F05
EIN
34-1818596

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Russell LowPRESIDENT AND CEO, Director154,900
Greg RedinboEVP and Chief Strategy Officer34,816
Christopher TatnallEVP Global Customer Operations27,491
David RyzhikSVP Interim CFO9,790
Gerald M. BlumenstockEVP, Research, Dev. & Eng.19,987
Robert John MahoneyEVP Global Operations14,410
Todd SuttonVP Corporate Controller6,360
Eileen EvansEVP, General Counsel and Sec'y31,295
James Gordon CooganEVP AND CFO37,144
Lynnette C. FallonEXECUTIVE VP, HR/LEGAL27,323
Necip SayinerDirector7,112
Dennis Thomas StDirector17,695
Gregory B. GravesDirector5,473
John T. KurtzweilDirector32,990
Jeanne QuirkDirector11,400
Tzu Yin ChiuDirector11,843
Jorge TitingerDirector5,917

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Dr.Low
$5.10M$6.44M$1.57M$276$253
FY2024
Dr.Low
$4.29M$1.62M$1.28M$290$269
FY2023
Dr.Low
$4.14M$6.51M$1.26M$538$226
FY2023
PEO1
$2.96M$9.86M$1.26M$538$226
FY2023
PEO2
$4.14M$6.51M$1.26M$538$226
FY2022
Dr.Low
$1.46M$1.75M$1.46M$329$137

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 1,465 employees and 50 agency temporary staff worldwide.”

Corporate history

Events identified from SEC filings